MarketInOut Stock Screener Log In | Sign Up
 

Edesa Biotech Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 05/08/2026
Edesa Biotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization78.1 mln
Float3.85 mln
Earnings Date05/08/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

14.00
Limited downside

Relative Strength

100 / 100
Top performer

Debt / Equity

0.00
Debt-free

ROE

-66.98
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

Edesa Biotech is a Canadian biopharmaceutical company focused on developing treatments for inflammatory and immune-related conditions, with a pipeline that includes both injectable antibody therapies and topical creams. Its most advanced programs target serious conditions such as acute respiratory distress syndrome, chronic skin allergies, and pulmonary fibrosis, with several candidates already in late-stage clinical trials. The company works alongside research partners in Switzerland and Israel to broaden the reach of its drug development efforts across human and animal health applications. Founded in 2015 and based in Markham, Ontario, Edesa continues to advance its portfolio from early research through to potential commercialization.

Key Fundamentals

EPS-1.07
ROE-66.98
ROIC-380
ROA-61.38
EBITDA, mln-7.67
EV / EBITDA-10.05
EV / EBIT-9.92

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price14.00
Short Ratio0.28
Short % of Float3.27

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.33% 11 / 100   
1 Month 175% 99 / 100   
2 Months 1293% 100 / 100   
6 Months 864% 100 / 100   
1 Year 615% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us